Materias dentro de su búsqueda.
Mostrando 401 - 420 Resultados de 1,014 Para Buscar '"Shareholder"', tiempo de consulta: 0.36s Limitar resultados
  1. 401
    “…(Employee)Spero Therapeutics (Grant/Research Support) Taylor Sandison, MD, MPH, Cidara Therapeutics, Inc. (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1174. Phase 2 STRIVE Clinical Trial of Rezafungin for Treatment of Candidemia and/or Invasive Candidiasis Demonstrates Consistent Trough Concentrations Across Diverse Patient Populations
  2. 402
    “…DISCLOSURES: Alexandra Bhatti, JD, MPH, Merck (Employee) Cristina Carias, PhD, Merck (Employee, Shareholder) Ya-Ting Chen, PhD, Merck & Co., Inc. (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1380. Current status of the legal landscape regarding Rotavirus Vaccination in the United States
  3. 403
    “…DISCLOSURES: Brooke Geibel, BS, Venatorx Pharmaceuticals (Employee, Shareholder) James A. Dowell, PhD, Venatorx Pharmaceuticals (Independent Contractor) Thomas C. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1318. Pharmacokinetics and Safety of Cefepime-Taniborbactam (formerly Cefepime/VNRX-5133) in Subjects with Renal Impairment
  4. 404
    “…DISCLOSURES: Ivo Vojtek, PharmD, PhD, MSc, FRSM, RPh, GSK Vaccines (Employee, Shareholder) Vanessa Palsenbarg, MA, GSK Vaccines (Employee, Shareholder) Joe Smyser, PhD, Public Good Project (Board Member, Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    65. Vaccine Confidence, COVID19, and the Influence of Peer Networks
  5. 405
    “…DISCLOSURES: Dustin Stwalley, MA, AbbVie Inc (Shareholder)Bristol-Myers Squibb (Shareholder) Margaret A. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    237. Inpatient and Discharge Antibiotic Use for Hospitalized Patients Growing Multi-Drug Resistant Bacteria in Urine Cultures
  6. 406
    “…DISCLOSURES: Yiyou Gu, PhD, Vitalex Biosciences (Shareholder) Ashraf S. Ibrahim, PhD, Vitalex Biosciences (Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    119. A Humanized Antibody Targeting the CotH Invasins is Protective Against Murine Mucormycosis
  7. 407
    “…DISCLOSURES: Erkan Hassan, Pharm.D., FCCM, Immunexpress (Consultant) Roy Davis, M.D>, Immunexpress (Consultant)Immunexpress (Consultant, Shareholder) Dayle Sampson, Ph.D., Immunexpress (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    994. Comparison of Lactate, Procalcitonin and a Gene Signature Assay Alone or in Combination to Differentiate Sepsis from Non-infectious Systemic Inflammation in ICU Patients
  8. 408
    “…(Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    523. Use of Immune-Viral Dynamics Modeling to Understand Molnupiravir Drug Effect for COVID-19
  9. 409
    “…DISCLOSURES: Dave ousterout, PhD, InceptorBio (Advisor or Review Panel member, Shareholder)Locus Biosciences (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1083. Phase 1b Results of Pharmacokinetics, Pharmacodynamics, and Safety for LBP-EC01, a CRISPR-Cas3 Enhanced Bacteriophage Cocktail Targeting Escherichia coli that Cause Urinary Tract Infections
  10. 410
    “…DISCLOSURES: T Matthew Hill, PharmD, PhD, Karius, Inc (Employee, Shareholder) Erick R. Scott, MD, MHS, Karius, Inc (Employee, Shareholder) Sivan Bercovici, PhD, Karius (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    928. Clinical Characteristics and Microbiology Testing Patterns Among Transplant Recipients Admitted to Acute Care Hospitals for Suspected Infection
  11. 411
    “…DISCLOSURES: Amine Amiche, PhD, Sanofi (Employee, Shareholder) Heidi Kabler, MD, Sanofi Pasteur (Employee) Janet Weeks, PhD, Becton, Dickinson and Company (Employee) Kalvin Yu, MD, BD (Employee) Vikas Gupta, PharmD, BCPS, Becton, Dickinson and Company (Employee, Shareholder)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    171. A Multicenter Analysis of Inpatient Antibiotic Use During the 2015-2019 Influenza Season in the US: Untapped Opportunities for Antimicrobial Stewardship
  12. 412
    “…DISCLOSURES: Jeffrey Vietri, PhD, Pfizer Inc (Employee, Shareholder) Kelley Meyers, PhD, RTI Health Solutions (Independent Contractor) Christine Poulos, PhD, Pfizer Inc (Other Financial or Material Support, Employee of RTI-HS, which received funds from Pfizer to conduct the study) Erica Chilson, PharmD, Pfizer, Inc (Employee, Shareholder) Vincenza Snow, MD, Pfizer Vaccines (Employee)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    06. United States Healthcare Provider Preferences for Adult Pneumococcal Vaccine Recommendations
  13. 413
    “…DISCLOSURES: Nishant Shah, MD, General Electric (Shareholder)Pfizer, Inc. (Research Grant or Support) Karen Visnaw, RN, Liquidia (Shareholder) Paul Monach, MD,PhD, Celgene (Consultant)ChemoCentryx (Consultant)Kiniksa (Advisor or Review Panel member)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    517. Subcutaneous Sarilumab for the Treatment of Hospitalized patients with Moderate to Severe COVID19 Disease: A Pragmatic, Embedded, Multi-Center Randomized Clinical Trial
  14. 414
    “…Lathouwers, Janssen: Employee and Shareholder, Salary. V. Hufkens, Janssen: Employee and Shareholder, Salary. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1768. Efficacy and Safety of Switching From Boosted-Protease Inhibitors (bPI) Plus Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) Regimens to the Once Daily (QD), Single-Tablet Regimen (STR) of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Virologically Suppressed, HIV-1-Infected Adults: Week 96 Results of the Phase 3, Randomized, Non-Inferiority EMERALD Trial
  15. 415
    “…(Employee, Shareholder) Diana M. Brainard, MD, Gilead Sciences (Employee) Sean E. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1002. A Daily Single Tablet Regimen (STR) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically-Suppressed Adults Living with HIV and End Stage Renal Disease on Chronic Hemodialysis
  16. 416
    “…Smith, PhD, Inovio (Employee, Shareholder) Kate Broderick, PhD, Inovio (Employee).…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    579. Design and Immunogenicity of a Pan-SARS-CoV-2 Synthetic DNA Vaccine
  17. 417
    “…Kumar, MD, AMGEN (Other Financial or Material Support, Honoraria)Eli Lilly (Grant/Research Support)Gilead (Grant/Research Support, Shareholder, Other Financial or Material Support, Honoraria)GSK (Grant/Research Support, Shareholder, Other Financial or Material Support, Honoraria)Merck & Co., Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1060. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections – First Case Series
  18. 418
    por Jenkins, Philip, Richardson, Peter R
    Publicado 2002
    “…In the era of rapidly changing technology, increased globalization opportunities and additional shareholder activity, today's executives are faced with the job of having to respond fast and efficiently to changes in the coporate climate. …”
    Enlace del recurso
    Fast forward: organizational change in 100 days
  19. 419
    por Desai, Vasant
    Publicado 2020
    “…They also drive towards top performance maintaining healthy profitability, enhancing shareholder value, responsive to customer needs, delivering products and services of high quality, and ability to thrive in a competitive environment. …”
    Enlace del recurso
    Project management and entrepreneurship
  20. 420
    por Veall, Michael R
    Publicado 2012
    “…Even so, I draw implications for policies that might achieve some support from across the political spectrum, including the elimination of tax preferences that favour those with high incomes, the promotion of shareholder democracy and, to maintain Canada's relatively high intergenerational mobility, continued wide accessibility to healthcare and education.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Top income shares in Canada: recent trends and policy implications
Herramientas de búsqueda: RSS